Table 7.
The prevalence of CYP2C19∗2, ∗3, ∗17, ABCB1, and PON1 polymorphisms in Uygur patients with CAD and Uygur healthy groups.

The prevalence of CYP2C19∗2, ∗3, ∗17, ABCB1, and PON1 polymorphisms in Uygur patients with CAD and Uygur healthy groups.
